Brief: NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
30/09/2025 12:03
Sept 30 (Reuters) - Kadimastem Ltd KDST.TA: NLS PHARMACEUTICS SHAREHOLDERS APPROVE MERGER WITH KADIMASTEM AND RELATED PROPOSALS AT EXTRAORDINARY GENERAL MEETING Source text: ID:nPn8TJKnBa Further company coverage: KDST.TA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing